Time to abandon the term angiomyolipoma for non-PEComatous angiomyomatous (or angiomatous) oral tumors with adipocytes

Konstantinos I. Tosios, Ioannis G Koutlas, Vasileios F. Kyriakopoulos, Maria Balta, Nandia Theologie-Lygidakis, Emmanuel Vardas, Ioannis Iatrou

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Angiomyolipoma (AML) is the most common benign mesenchymal neoplasm of the kidneys with well-established clinical and morphological features. The oral and maxillofacial pathology literature contains several examples that identify angiomyomatous proliferations of the oral mucosa that contain an adipocytic component as analogous to classic renal AMLs although they differ significantly in their immunohistochemical phenotype. Herein, through review of the pertinent oral pathology literature and the detailed description of 2 lesions, one an oral angiomyoma with an adipocytic component and the other an apparently hamartomatous angioleiomyomatous proliferation with adipocytes, we provide, in our opinion, a solid argument against the use of the term AML for non-PEComatous oral tumors.

Original languageEnglish (US)
Pages (from-to)492-497
Number of pages6
JournalOral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology
Volume110
Issue number4
DOIs
StatePublished - Oct 1 2010

Fingerprint Dive into the research topics of 'Time to abandon the term angiomyolipoma for non-PEComatous angiomyomatous (or angiomatous) oral tumors with adipocytes'. Together they form a unique fingerprint.

Cite this